257 related articles for article (PubMed ID: 34706132)
1. Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
Liu S; Jiang Z; Xiao P; Li X; Chen Y; Tang H; Chai Y; Liu Y; Zhu Z; Xie Q; He W; Ma Y; Jin L; Feng W
Cancer Sci; 2022 Jan; 113(1):79-90. PubMed ID: 34706132
[TBL] [Abstract][Full Text] [Related]
2. circ_PPAPDC1A promotes Osimertinib resistance by sponging the miR-30a-3p/ IGF1R pathway in non-small cell lung cancer (NSCLC).
Tang YF; Liu ZH; Zhang LY; Shi SH; Xu S; Ma JA; Hu CH; Zou FW
Mol Cancer; 2024 May; 23(1):91. PubMed ID: 38715012
[TBL] [Abstract][Full Text] [Related]
3. Hsa_circ_0070661 inhibits cancer progression through miR-556-5p/TEK axis in lung adenocarcinoma.
Chen Y; Wu Y
Cancer Biomark; 2023; 37(1):53-66. PubMed ID: 37005879
[TBL] [Abstract][Full Text] [Related]
4. Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
Wang L; Li M; Lian R
Histol Histopathol; 2022 Jul; 37(7):637-654. PubMed ID: 35133000
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circ-TSPAN4 promotes lung adenocarcinoma metastasis by upregulating ZEB1 via sponging miR-665.
Ying X; Zhu J; Zhang Y
Mol Genet Genomic Med; 2019 Dec; 7(12):e991. PubMed ID: 31573758
[TBL] [Abstract][Full Text] [Related]
6. The novel circular RNA circ-CAMK2A enhances lung adenocarcinoma metastasis by regulating the miR-615-5p/fibronectin 1 pathway.
Du J; Zhang G; Qiu H; Yu H; Yuan W
Cell Mol Biol Lett; 2019; 24():72. PubMed ID: 31889960
[TBL] [Abstract][Full Text] [Related]
7. Activation of insulin-like growth factor-1 receptor confers acquired resistance to osimertinib in non-small cell lung cancer with EGFR T790M mutation.
Hayakawa D; Takahashi F; Mitsuishi Y; Tajima K; Hidayat M; Winardi W; Ihara H; Kanamori K; Matsumoto N; Asao T; Ko R; Shukuya T; Takamochi K; Hayashi T; Suehara Y; Takeda Nakamura I; Ueno T; Kohsaka S; Mano H; Takahashi K
Thorac Cancer; 2020 Jan; 11(1):140-149. PubMed ID: 31758670
[TBL] [Abstract][Full Text] [Related]
8. A novel osimertinib-resistant human lung adenocarcinoma cell line harbouring mutant EGFR and activated IGF1R.
Makimoto G; Ninomiya K; Kubo T; Sunami R; Kato Y; Ichihara E; Ohashi K; Rai K; Hotta K; Tabata M; Maeda Y; Kiura K
Jpn J Clin Oncol; 2021 May; 51(6):956-965. PubMed ID: 33829270
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0129047 regulates the miR-375/ACVRL1 axis to attenuate the progression of lung adenocarcinoma.
Fan J; Xia X; Fan Z
J Clin Lab Anal; 2022 Sep; 36(9):e24591. PubMed ID: 35908770
[TBL] [Abstract][Full Text] [Related]
10. Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.
Sun Z
Life Sci; 2020 Oct; 259():118157. PubMed ID: 32735888
[TBL] [Abstract][Full Text] [Related]
11. Construction of a circRNA-miRNA-mRNA Regulated Pathway Involved in EGFR-TKI Lung Adenocarcinoma Resistance.
Dai C; Liu B; Li S; Hong Y; Si J; Xiong Y; Wu N; Ma Y
Technol Cancer Res Treat; 2021; 20():15330338211056809. PubMed ID: 34825849
[No Abstract] [Full Text] [Related]
12. Circular RNA circCSNK1G3 induces HOXA10 signaling and promotes the growth and metastasis of lung adenocarcinoma cells through hsa-miR-143-3p sponging.
Lu T; Qiu T; Han B; Wang Y; Sun X; Qin Y; Liu A; Ge N; Jiao W
Cell Oncol (Dordr); 2021 Apr; 44(2):297-310. PubMed ID: 33118120
[TBL] [Abstract][Full Text] [Related]
13. CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway.
Wang Y; Yin L; Sun X
J Exp Clin Cancer Res; 2020 Aug; 39(1):169. PubMed ID: 32847606
[TBL] [Abstract][Full Text] [Related]
14. Hsa_circ_0001361 facilitates the progress of lung adenocarcinoma cells via targeting miR-525-5p/VMA21 axis.
Shen HY; Shi LX; Wang L; Fang LP; Xu W; Xu JQ; Fan BQ; Fan WF
J Transl Med; 2021 Sep; 19(1):389. PubMed ID: 34507559
[TBL] [Abstract][Full Text] [Related]
15. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of hsa_circ_0008274 inhibited the progression of lung adenocarcinoma by regulating HMGA2 via sponging miR-578.
Wang M; Ma M; Yang Y; Li C; Wang Y; Sun X; Wang M; Sun Y; Jiao W
Thorac Cancer; 2021 Aug; 12(16):2258-2264. PubMed ID: 34236145
[TBL] [Abstract][Full Text] [Related]
17. A two-circular RNA signature as a noninvasive diagnostic biomarker for lung adenocarcinoma.
Liu XX; Yang YE; Liu X; Zhang MY; Li R; Yin YH; Qu YQ
J Transl Med; 2019 Feb; 17(1):50. PubMed ID: 30777071
[TBL] [Abstract][Full Text] [Related]
18. Homo sapiens circular RNA 0003602 (Hsa_circ_0003602) accelerates the tumorigenicity of acute myeloid leukemia by modulating miR-502-5p/IGF1R axis.
Ye Q; Li N; Zhou K; Liao C
Mol Cell Biochem; 2022 Feb; 477(2):635-644. PubMed ID: 34988853
[TBL] [Abstract][Full Text] [Related]
19. Hsa-miR-503-5p regulates CTDSPL to accelerate cisplatin resistance and angiogenesis of lung adenocarcinoma cells.
Han J; Wang Y
Chem Biol Drug Des; 2023 Oct; 102(4):749-762. PubMed ID: 37341065
[TBL] [Abstract][Full Text] [Related]
20. CircRNA ZKSCAN1 promotes lung adenocarcinoma progression by miR-185-5p/TAGLN2 axis.
Yu N; Gong H; Chen W; Peng W
Thorac Cancer; 2023 Jun; 14(16):1467-1476. PubMed ID: 37105934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
